A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis (NCT05862272)
A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids or Moderate to Severe Pain Associated With Endometriosis
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with heavy menstrual bleeding associated with uterine leiomyomas (fibroids) or with moderate-to-severe pain associated with endometriosis.
Who can join: Review the eligibility criteria below.
Location: Mobile — Mobile, Alabama
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (120 Sites)
Showing the first 25 of 120 sites.
- Mobile — Mobile, Alabama
- Chandler — Chandler, Arizona
- Mesa — Mesa, Arizona
- Peoria — Peoria, Arizona
- Phoenix — Phoenix, Arizona
- Tucson — Tucson, Arizona
- Burbank — Burbank, California
- Canoga Park — Canoga Park, California
- Encinitas — Encinitas, California
- Inglewood — Inglewood, California
- Lomita — Lomita, California
- Long Beach — Long Beach, California
- Los Angeles — Los Angeles, California
- Sacramento — Sacramento, California
- San Fernando — San Fernando, California
- Stanford — Stanford, California
- Valley Village — Valley Village, California
- Aurora — Aurora, Colorado
- Greenwood Village — Greenwood Village, Colorado
- Lakewood — Lakewood, Colorado
- Washington — Washington D.C., District of Columbia
- Aventura — Aventura, Florida
- Deland — DeLand, Florida
- Hialeah — Hialeah, Florida
- Kissimmee — Kissimmee, Florida
📞 Contact the Study Coordinator
Phone: (650) 278-8743
Email: ClinicalTrials@Myovant.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Uterine Fibroids
- Effect of Addition of Steroids on Duration of Analgesia — Westwood, Los Angeles, California
- Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry — Irvine, California
- An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms — Las Vegas, Nevada
Explore by condition: All Uterine Fibroids clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.